MediPal Holdings Corporation
7459.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥952 | ¥945 | ¥864 | ¥983 |
| % Growth | 0.8% | 9.4% | -12% | – |
| Cost of Goods Sold | ¥890 | ¥880 | ¥806 | ¥915 |
| Gross Profit | ¥62 | ¥65 | ¥58 | ¥68 |
| % Margin | 6.5% | 6.8% | 6.7% | 6.9% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥41 | ¥42 | ¥40 |
| SG&A Expenses | ¥51 | ¥47 | ¥48 | ¥46 |
| Sales & Mktg Exp. | ¥0 | ¥6 | ¥6 | ¥6 |
| Other Operating Expenses | ¥0 | ¥3 | ¥0 | ¥3 |
| Operating Expenses | ¥51 | ¥51 | ¥48 | ¥50 |
| Operating Income | ¥11 | ¥14 | ¥10 | ¥18 |
| % Margin | 1.2% | 1.5% | 1.2% | 1.9% |
| Other Income/Exp. Net | ¥10 | ¥5 | ¥1 | ¥8 |
| Pre-Tax Income | ¥21 | ¥19 | ¥11 | ¥26 |
| Tax Expense | ¥6 | ¥6 | ¥4 | ¥9 |
| Net Income | ¥13 | ¥10 | ¥4 | ¥15 |
| % Margin | 1.3% | 1% | 0.5% | 1.5% |
| EPS | 60.63 | 46.17 | 19.43 | 69.78 |
| % Growth | 31.3% | 137.6% | -72.2% | – |
| EPS Diluted | 60.63 | 46.17 | 19.43 | 69.78 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥5 | ¥3 | ¥5 | ¥5 |
| EBITDA | ¥26 | ¥17 | ¥15 | ¥31 |
| % Margin | 2.7% | 1.8% | 1.8% | 3.1% |